EASY BIO,Inc. (353810.KQ)

KRW 4570.0

(0.44%)

Gross Profit Summary of EASY BIO,Inc.

EASY BIO,Inc.'s latest annual gross profit in 2023 was 50.88 Billion KRW , up 7.62% from previous year.
EASY BIO,Inc.'s latest quarterly gross profit in 2024 Q2 was 27.2 Billion KRW , up 51.3% from previous quarter.
EASY BIO,Inc. reported a annual gross profit of 47.28 Billion KRW in annual gross profit 2022, up 16.37% from previous year.
EASY BIO,Inc. reported a annual gross profit of 40.63 Billion KRW in annual gross profit 2021, up 36.98% from previous year.
EASY BIO,Inc. reported a quarterly gross profit of 17.97 Billion KRW for 2024 Q1, up 35.73% from previous quarter.
EASY BIO,Inc. reported a quarterly gross profit of 11.72 Billion KRW for 2023 Q1, up 6.19% from previous quarter.

Annual Gross Profit Chart of EASY BIO,Inc. (2023 - 2020)

Historical Annual Gross Profit of EASY BIO,Inc. (2023 - 2020)

Year	Gross Profit	Gross Profit Growth
2023	50.88 Billion KRW	7.62%
2022	47.28 Billion KRW	16.37%
2021	40.63 Billion KRW	36.98%
2020	29.66 Billion KRW	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	27.2 Billion KRW	51.3%
2024 Q1	17.97 Billion KRW	35.73%
2023 Q1	11.72 Billion KRW	6.19%
2023 FY	50.88 Billion KRW	7.62%
2023 Q4	13.24 Billion KRW	-3.82%
2023 Q3	13.77 Billion KRW	6.27%
2023 Q2	12.95 Billion KRW	10.52%
2022 FY	47.28 Billion KRW	16.37%
2022 Q3	12.56 Billion KRW	-0.64%
2022 Q4	11.04 Billion KRW	-12.13%
2022 Q2	12.64 Billion KRW	14.71%
2022 Q1	11.02 Billion KRW	-4.43%
2021 Q1	9.98 Billion KRW	-3.71%
2021 FY	40.63 Billion KRW	36.98%
2021 Q4	11.53 Billion KRW	16.16%
2021 Q3	9.93 Billion KRW	8.18%
2021 Q2	9.18 Billion KRW	-8.01%
2020 FY	29.66 Billion KRW	0.0%
2020 Q4	10.36 Billion KRW	-15.21%
2020 Q3	12.22 Billion KRW	72.79%
2020 Q2	7.07 Billion KRW	0.0%

Peer Gross Profit Comparison of EASY BIO,Inc.

Name	Gross Profit	Gross Profit Difference
HLB Co., Ltd.	-6.01 Billion KRW	946.339%
iNtRON Biotechnology, Inc.	4.56 Billion KRW	-1015.707%
BINEX Co., Ltd.	56.65 Billion KRW	10.183%
Bioneer Corporation	199.25 Billion KRW	74.462%
Anterogen.Co.,Ltd.	2.21 Billion KRW	-2198.954%
MEDIPOST Co., Ltd.	40.18 Billion KRW	-26.632%
CrystalGenomics, Inc.	1.45 Billion KRW	-3392.504%
Helixmith Co., Ltd	2.12 Billion KRW	-2298.188%
Chabiotech Co.,Ltd.	255.19 Billion KRW	80.06%
Medy-Tox Inc.	128.16 Billion KRW	60.296%
Peptron, Inc.	1.14 Billion KRW	-4361.416%
Amicogen, Inc.	51.51 Billion KRW	1.217%
Genexine, Inc.	387.48 Million KRW	-13032.379%
HLB Therapeutics Co.,Ltd.	6.69 Billion KRW	-660.144%
LegoChem Biosciences, Inc.	17.79 Billion KRW	-185.92%
ALTEOGEN Inc.	31.19 Billion KRW	-63.104%
PharmaResearch Co., Ltd.	182.25 Billion KRW	72.08%
SillaJen, Inc.	1.45 Billion KRW	-3393.134%
JETEMA, Co., Ltd.	26.58 Billion KRW	-91.43%
OliX Pharmaceuticals,Inc	14.42 Billion KRW	-252.828%
Genomictree Inc.	-1.03 Billion KRW	4999.508%
MedPacto, Inc.	-1.83 Billion KRW	2876.611%
D&D Pharmatech	18.67 Billion KRW	-172.452%
GI Innovation, Inc.	1.98 Billion KRW	-2457.826%